List of Excipients in Branded Drug NEFAZODONE HYDROCHLORIDE

Generic Drugs Containing NEFAZODONE HYDROCHLORIDE

Company	Ingredient	NDC	Excipient
Teva Pharmaceuticals USA Inc	nefazodone hydrochloride	0093-7178	CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc	nefazodone hydrochloride	0093-7178	FERRIC OXIDE RED
Teva Pharmaceuticals USA Inc	nefazodone hydrochloride	0093-7178	MAGNESIUM STEARATE

What are the Most Frequently-Used Excipients in NEFAZODONE HYDROCHLORIDE?

# Of NDCs	Excipient
7	CELLULOSE, MICROCRYSTALLINE
1	COLLOIDAL SILICON DIOXIDE
3	FERRIC OXIDE RED

Excipient Strategy and Commercial Opportunities for Nafazodone Hydrochloride

Last updated: March 7, 2026

What are the key excipient considerations for Nafazodone Hydrochloride formulations?

Nafazodone Hydrochloride is an antidepressant drug with a mechanism involving serotonin modulation. Its formulation challenges include stability, bioavailability, and patient tolerability, which influence excipient selection.

Essential excipient roles include:

• Disintegrants: Facilitate tablet break-up in the gastrointestinal tract. Crospovidone and croscarmellose sodium are typical choices.
• Binders: Maintain tablet integrity. Microcrystalline cellulose and povidone are common.
• Fillers: Adjust bulk; microcrystalline cellulose and lactose are preferred.
• Lubricants: Minimize tablet manufacturing friction; magnesium stearate is standard.
• Give-release modifiers: To control drug release, methacrylate coatings or hydroxypropyl methylcellulose can be used.

Stability considerations:

Nafazodone is susceptible to hydrolysis and oxidation. Excipients like antioxidants (e.g., ascorbic acid) and moisture scavengers can improve shelf life.

Formulation formats:

• Immediate-release tablets primarily employ disintegrants, binders, and lubricants.
• Extended-release formulations often involve polymer matrices (e.g., ethylcellulose) and controlled-release coatings.

What are the commercial opportunities related to excipient choices?

Differentiation through formulation innovation:

• Developing novel controlled-release systems can improve patient adherence.
• Using bioenhancers or absorption modifiers can increase bioavailability, enabling lower doses and reducing side effects.

Cost implication and supply chain:

• Excipients like microcrystalline cellulose are globally available; others, such as specialized polymers, may involve supply constraints.
• Scaling up manufacturing requires stable partnerships with excipient suppliers, with considerations for regulatory compliance and quality control.

Regulatory landscape:

• Regulatory agencies (FDA, EMA) assess excipient safety, especially for new or less common excipients.
• Demonstrating excipient safety and compatibility with Nafazodone is critical to gaining approval.

Market potential:

• The global antidepressant market is projected to reach USD 15 billion by 2025 (Grand View Research, 2021).
• Differentiation through improved formulation can command premium pricing and address unmet needs like reduced side effects and enhanced convenience.

Intellectual property opportunities:

• Patents around novel excipient combinations or controlled-release systems can provide competitive protection.
• Proprietary excipient blends can serve as barriers to entry for competitors.

What are the manufacturing and regulatory implications?

• Excipient quality impacts drug stability, efficacy, and bioavailability.
• Manufacturing specifications must meet pharmacopeial standards (USP, EP).
• Regulatory filings must include excipient sources, specifications, and qualification data.

Summary of excipient strategies:

Strategy	Implication	Market Opportunity
Use of advanced controlled-release polymers	Extends patent life, improves adherence	Premium products, differentiation
Incorporate antioxidants and stabilizers	Enhances shelf life	Expanded market reach, reduced waste
Develop novel bioavailability enhancers	Increases efficacy at lower doses	Cost savings, competitive edge

Key Takeaways

• Excipient selection impacts Nafazodone Hydrochloride’s stability, bioavailability, and patient compliance.
• Formulation innovations, especially controlled-release systems, can create high-value commercial opportunities.
• Supply chain security and regulatory approval are critical for excipient-related innovations.
• Patent strategies around excipient combinations and delivery systems provide competitive barriers.
• Cost management involves selecting readily available excipients without compromising quality.

FAQs

1. What are the primary challenges in formulating Nafazodone Hydrochloride?
Stability issues due to hydrolysis and oxidation, poor bioavailability, and tolerability concerns.

2. How can excipients improve Nafazodone stability?
Antioxidants and moisture scavengers mitigate oxidation; suitable coatings prevent hydrolysis.

3. Are there specific excipients suitable for controlled-release formulations?
Yes. Ethylcellulose, hydroxypropyl methylcellulose, and acrylic polymers are common.

4. What is the market outlook for formulations with advanced excipients?
Growing demand for better-tolerated, convenient antidepressant medications supports market expansion.

5. How do regulatory considerations influence excipient choices?
Excipients must be approved and documented for safety and compatibility; novel excipients require extensive validation.

References

[1] Grand View Research. (2021). Antidepressant Drugs Market Size, Share & Trends Analysis Report.